Thyroid cancer is the most common endocrine malignancy. Although most thyroid cancer patients are successfully treated and have an excellent prognosis, a percentage of these patients will develop aggressive disease and, eventually, progress to anaplastic thyroid cancer. Since most patients with this type of aggressive thyroid carcinoma will die from the disease, new treatment strategies are urgently needed. Tumor cells live in a complex and dynamic tumor microenvironment composed of different types of stromal cells. Cancer-associated fibroblasts (CAFs) are one of the most important cell components in the tumor microenvironment of most solid tumors, including thyroid cancer. CAFs originate mainly from mesenchymal cells and resident fibroblasts that are activated and reprogrammed in response to paracrine factors and cytokines produced and released by tumor cells. Upon reprogramming, which is distinguished by the expression of different marker proteins, CAFs synthesize and secret soluble factors. The secretome of CAFs directly impacts different functions of tumor cells. This bi-directional interplay between CAFs and tumor cells within the tumor microenvironment ends up fostering tumor cancer progression. CAFs are therefore key regulators of tumor progression and represent an under-explored therapeutic target in thyroid cancer.
Citations
Citations to this article as recorded by
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, Miriam Conte, Elisabetta Maria Abenavoli, Ambra Buschiazzo, Greta Celesti, Francesco Dondi, Rossella Filice, Joana Gorica, Lorenzo Jonghi-Lavarini, Riccardo Laudicella, Maria Librando, Flavia Linguanti Cancers.2024; 16(4): 839. CrossRef
Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer Ece Ozmen, Tevriz Dilan Demir, Gulnihal Ozcan Frontiers in Molecular Biosciences.2024;[Epub] CrossRef
Co-cultivation of human granulosa cells with ovarian cancer cells leads to a significant increase in progesterone production Detlef Pietrowski, Martina Grgic, Isabella Haslinger, Julian Marschalek, Christian Schneeberger Archives of Gynecology and Obstetrics.2023; 307(5): 1593. CrossRef
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer Deepshikha Mishra, Debabrata Banerjee Cells.2023; 12(4): 628. CrossRef
Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, Shobhana Raju, Swayamjeet Satapathy, Parvind Sheokand, Euy Sung Moon, Marcel Martin, Shipra Awarwal, Madhavi Tripathi, Chandrasekhar Bal Thyroid®.2023; 33(8): 974. CrossRef
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Swayamjeet Satapathy, Euy Sung Moon, Marcel Martin, Nicky Wakade, Parvind Sheokand, Madhavi Tripathi, Kunal R. Chandekar, Shipra Agarwal, Ranjit Kumar Sahoo, Sameer Rastogi, Chandrasekhar Bal European Journal of Nuclear Medicine and Molecular Imaging.2023; 51(1): 233. CrossRef
Identifying the cancer-associated fibroblast signature to predict the prognosis and immunotherapy response in patients with lung squamous cell carcinoma Yinhui Zhu, Yingqun Zhu, Sirui Chen, Qian Cai Computer Methods in Biomechanics and Biomedical Engineering.2023; : 1. CrossRef
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer Qi Liu, Wei Sun, Hao Zhang Frontiers in Pharmacology.2022;[Epub] CrossRef
Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway Xue Luo, Jinping Wang, Jinxi Lu, Xi Wang, Yuan Miao, Qingchang Li, Xiaoman Li, Liang Wang, Yong Xin Ma BioMed Research International.2022; 2022: 1. CrossRef
Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling Rocío del Carmen Bravo-Miana, María Florencia Soler, Danilo Guillermo Ceschin, Félix Royo, Dana María Negretti-Borga, Mikel Azkargorta, Félix Elortza, María del Mar Montesinos, Claudia Gabriela Pellizas, Juan Manuel Falcón-Pérez, Ana Carolina Donadio European Journal of Cell Biology.2022; 101(3): 151254. CrossRef
The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway Zhen-xing Yu, Cheng Xiang, Sheng-gui Xu, Yang-ping Zhang Medicine.2022; 101(31): e29972. CrossRef
Thyroid Cancer and Fibroblasts Angelica Avagliano, Giuseppe Fiume, Claudio Bellevicine, Giancarlo Troncone, Alessandro Venuta, Vittoria Acampora, Sabrina De Lella, Maria Rosaria Ruocco, Stefania Masone, Nunzio Velotti, Pietro Carotenuto, Massimo Mallardo, Carmen Caiazza, Stefania Monta Cancers.2022; 14(17): 4172. CrossRef
TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target Luz Maria Palacios, Victoria Peyret, María Estefania Viano, Romina Celeste Geysels, Yair Aron Chocobar, Ximena Volpini, Claudia Gabriela Pellizas, Juan Pablo Nicola, Claudia Cristina Motran, María Cecilia Rodriguez-Galan, Laura Fozzatti Biology.2022; 11(11): 1609. CrossRef
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma Zhao-Shan Niu, Wen-Hong Wang, Xiao-Jun Niu World Journal of Gastroenterology.2022; 28(46): 6433. CrossRef
Recent advances in regenerative medicine strategies for cancer treatment Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, Leila Sabouri, Mohammad Varzandeh, Nima Rezaei Biomedicine & Pharmacotherapy.2021; 141: 111875. CrossRef
Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-yann Cheng, Claudia Gabriela Pellizas, Laura Fozzatti Cancers.2021; 13(19): 4821. CrossRef
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Frank Roesch, Samta Kumari, Shipra Agarwal, Madhavi Tripathi, Ranjit Kumar Sahoo, Bharadwaj Srinivas Mangu, Avinash Tupalli, Chandrasekhar Bal Thyroid.2021;[Epub] CrossRef
Emerging Biomarkers in Thyroid Practice and Research Shipra Agarwal, Andrey Bychkov, Chan-Kwon Jung Cancers.2021; 14(1): 204. CrossRef